NEWS
  2011/11/17  
 
Asia Society Selects George Yeh to represent Taiwan at the Asia 21 Young Leaders Summit
  2011/11/11  
 
TLC presents TLC388 in EORTC-NCI-AACR International Symposium
  2011/11/08  
 
New Formulation Drugs grows in Importance


 
     
 
Technologies Advanceed
  TLC focuses on the R&D and commercialization of innovative pharmaceutical products based on its proprietary drug delivery technologies.  
 
Products Enhanced
  TLC's proprietary DDS technologies can effectively reduce drug toxicity, allowing patients to receive higher and more effective doses.  
 
People Motivated
  In the process of delivering hope for life, TLC is hoping to become one of world's leading biotech companies.